Overview

A Trial of ZL-1201 in Subjects With Advanced Cancer

Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
First in Human, Phase I Trial of ZL-1201 in Subjects with Advanced Cancer
Phase:
Phase 1
Details
Lead Sponsor:
Zai Lab (Shanghai) Co., Ltd.
Collaborator:
PPD
Treatments:
Antibodies